ctrl K

Watchlist Price Alert

Zynerba Pharmaceuticals I... (ZYNE)

NASDAQ: ZYNE · Real-Time Price · USD

1.30

0.03 (2.36%)

At close: Oct 10, 2023, 10:00 PM

Zynerba Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	86K	7.25K	7.25K
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	86K	7.25K	7.25K
Operating Income	-35.25M	-36.77M	-52.06M	-34.32M	-40.4M	-32.82M	-23.21M
Interest Income	846.86K	21.05K	243.99K	1.52M	961.32K	519.55K	80.22K
Pretax Income	-35.04M	-37.31M	-51.34M	-32.94M	-39.91M	-32.01M	-23.42M
Net Income	-34.82M	-37.6M	-50.4M	-31.43M	-39.91M	-32.01M	-23.39M
Selling & General & Admin	14.15M	15.35M	16.41M	13.94M	13.24M	10.02M	6.43M
Research & Development	21.1M	21.42M	35.65M	20.38M	27.25M	22.81M	16.78M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	35.25M	36.77M	52.06M	34.32M	40.48M	32.82M	23.21M
Interest Expense	-215.73K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	35.25M	36.77M	52.06M	34.32M	40.48M	32.82M	23.21M
Income Tax Expense	-215.73K	291.49K	-932.75K	-1.51M	486.65K	-27.54K	-27.54K
Shares Outstanding (Basic)	42.66M	39.26M	27.02M	22M	15.31M	12.91M	9.07M
Shares Outstanding (Diluted)	42.66M	39.26M	27.02M	22M	15.31M	12.91M	9.07M
EPS (Basic)	-0.82	-0.96	-1.87	-1.43	-2.61	-2.48	-2.58
EPS (Diluted)	-0.82	-0.96	-1.87	-1.43	-2.61	-2.48	-2.58
EBITDA	-34.62M	-36.21M	-52.06M	-34.17M	-40.4M	-32.82M	-23.21M
EBIT	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	631.13K	559.68K	-481.72K	145.91K	99.57K	94.21K	75.3K